Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL5863178 | 0.93 | KDM4E (0.43) | KCNA5MAPK1NPC1RAB9AKDM4E | |
| SCHEMBL5863067 | 0.92 | HTT (0.44) | KCNA5MAPK1NPC1RAB9AKDM4E | |
| Oxalic Acid SCHEMBL5863493 | 0.87 | KDM4E (0.45) | MAPK1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL5863083 | 0.84 | ALDH1A1 (0.50) | NPC1RAB9ASMN1; SMN2KMT2APOLB | |
| Oxalic Acid SCHEMBL5863143 | 0.84 | FYN (0.46) | NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL5863297 | 0.81 | KDM4E (0.41) | MAPK1NPC1RAB9AKDM4ESMN1; SMN2 | |
| SCHEMBL5638018 | 0.81 | MAPK1 (0.40) | MAPK1NPC1RAB9AKDM4ESMN1; SMN2 | |
| Oxalic Acid SCHEMBL5863081 | 0.81 | KDM4E (0.44) | NPC1RAB9AKDM4ESMN1; SMN2KMT2A | |
| Oxalic Acid SCHEMBL5863262 | 0.79 | FYN (0.46) | NPC1RAB9AKDM4ESMN1; SMN2KMT2A | |
| SCHEMBL5863100 | 0.79 | FYN (0.46) | NPC1RAB9AKDM4ESMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7132456-B2 | MCH receptor antagonists | ELI LILLY AND COMPANY (US) | 2006-11-07 | — | — | US | disclosed |
| US-20060052449-A1 | Novel mch receptor antagonists | ELI LILLY AND COMPANY | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052449-A1 | Novel mch receptor antagonists | MCHR1, MCHR2, MC1R | KCNA5 1296/4885MAPK1 989/4885NPC1 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.